# Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism

> **NCT02999399** · PHASE1 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 39 (actual)

## Conditions studied

- Smoking

## Interventions

- **OTHER:** Brussel Sprouts
- **DRUG:** Deuterated Phenanthrene

## Key facts

- **NCT ID:** NCT02999399
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2021-03-22
- **Final completion:** 2021-03-22
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02999399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02999399, "Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT02999399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*